New research suggests that patients who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who end traditional lifestyle programs.
Research printed in a prominent health publication shows that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Users buying these treatments must be informed of the danger of rapid weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain means a reversion to original weight within about one and a half years.
Comparing Therapies
The analysis, which examined 37 of trials involving thousands of participants, compared the outcomes of these new drugs with other pills.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone generally have a slower weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Rapid Regain
Nutrition scientists believe the way of the drugs accounts for the accelerated regain.
The injections copy a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication leads to appetite is unsuppressed, making binge eating much more probable."
A Lifelong Disease?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians say that, considering the high risk of relapse, the therapy is often ongoing.
This perspective is echoed by drug manufacturers, who note that the results "highlight the chronic nature of excess weight," akin to managing diseases like diabetes.
Patient Accounts
People who have discontinued the jabs explain a sudden resurgence of appetite.
"It felt as if a switch that goes on and I was suddenly starving," recalled an individual.
This challenge is exacerbated if patients have not developed sustainable dietary or behavioural changes during therapy.
Growing Adoption
Survey data show that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Adoption is greater among females than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Finally, experts emphasize that while the jabs are effective agents for weight loss, they are not a magic fix and maintained weight loss relies on integrated lifestyle support.
